Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

3.61
Delayed Data
As of Mar 24
 -0.05 / -1.37%
Today’s Change
1.51
Today|||52-Week Range
9.78
+76.96%
Year-to-Date

Today’s Trading

Previous close3.66
Today’s open3.67
Day’s range3.52 - 3.68
Volume1,266,913
Average volume (3 months)2,005,028
Market cap$319.7M
Dividend yield--
Data as of 4:00pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...+0.02+0.66%
BOLDAudentes Therapeutic...+1.35+8.73%
GERNGeron Corp+0.01+0.47%
ADAPAdaptimmune Therapeu...+0.01+0.23%
Data as of 4:00pm ET, 03/24/2017

Financials

Next reporting dateMay 31, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs